Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase NA 1

Status

Completed 2Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Neoplasms 2012Carcinoma, Non-Small-Cell Lung 1228Breast Neoplasms 1215Leukemia, Myeloid, Acute 967Neoplasm Metastasis 902Melanoma 778Colorectal Neoplasms 752Multiple Myeloma 725Lymphoma 725Ovarian Neoplasms 675Pancreatic Neoplasms 665Lymphoma, Non-Hodgkin 659Prostatic Neoplasms 657Recurrence 637Precursor Cell Lymphoblastic Leukemia-Lymphoma 585Lung Neoplasms 560Leukemia, Lymphocytic, Chronic, B-Cell 555Glioblastoma 527Leukemia 486Lymphoma, Large B-Cell, Diffuse 440Lymphoma, Follicular 419Brain Neoplasms 415Squamous Cell Carcinoma of Head and Neck 389Stomach Neoplasms 387Carcinoma, Renal Cell 385Myelodysplastic Syndromes 382Carcinoma, Hepatocellular 368Advanced Solid Tumors 357Lymphoma, Mantle-Cell 345Glioma 343

Interventions

fludarabine 1carotuximab 1Gemcitabine 1Cyclophosphamide 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Adult Solid Tumor × Clear all
NCT05147272 2025-12-05

Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

Debiopharm International SA

Phase 1 Terminated
67 enrolled 22 charts
Other solid neoplasm

Adult Solid Tumor

NCT06277804 2024-02-26

A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor

Letolab

Phase 1 Not yet recruiting
48 enrolled
Other solid neoplasm

Adult Solid Tumor

NCT05400265 2024-02-06

Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor

Shanghai Henlius Biotech

Phase 1 Completed
9 enrolled
Other solid neoplasm

Adult Solid Tumor

NCT05666635 2022-12-28

Study of LTC004 in Subjects With Advanced Malignant Tumors

Letolab

Phase 1 Unknown
368 enrolled
Other solid neoplasm

Adult Solid Tumor

NCT01332721 2018-12-05

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated

Tracon Pharmaceuticals Inc.

Phase 1 Completed
38 enrolled 8 charts
Other solid neoplasm

Adult Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡